Global Ribonucleic Acid Ingredients 麻豆原创 Research Report 2023

Publication ID:

PB510235813

Publication Date:

October 17, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A synthesized from DNA by an enzyme known as RNA polymerase during a process called transcription.
The global Ribonucleic Acid Ingredients market is projected to reach US$ 5223.9 million in 2029, increasing from US$ 3350 million in 2022, with the CAGR of 6.6% during the period of 2023 to 2029.
The global ribonucleic acid (RNA) ingredients market refers to the industry involved in the production and distribution of various RNA-based ingredients used in different sectors, including pharmaceuticals, biotechnology, agriculture, and research laboratories. RNA ingredients play a crucial role in a wide range of applications, including therapeutic development, gene expression analysis, genetic engineering, and molecular diagnostics.
Here are some key insights into the global RNA ingredients market:
麻豆原创 Overview:
The global RNA ingredients market has been witnessing steady growth due to the increasing adoption of RNA-based technologies in various industries. RNA ingredients are widely used for their ability to regulate gene expression, perform cellular functions, and as tools in molecular biology research.
Types of RNA Ingredients:
The market for RNA ingredients can be categorized based on their types, including:
Messenger RNA (mRNA): mRNA is a form of RNA that carries genetic information from DNA to the ribosomes, where it is used as a template for protein synthesis. mRNA ingredients find applications in vaccine development, gene therapy, and regenerative medicine.
Transfer RNA (tRNA): tRNA molecules play a crucial role in protein synthesis by delivering amino acids to the ribosomes. tRNA ingredients are used in various research and diagnostic applications involving protein synthesis and translation.
Ribosomal RNA (rRNA): rRNA molecules are a component of ribosomes, the cellular machinery responsible for protein synthesis. rRNA ingredients find applications in research laboratories and biotechnological processes involved in protein production.
Small Interfering RNA (siRNA): siRNA molecules are used in genetic research and therapeutics to selectively inhibit the expression of target genes. siRNA ingredients have potential applications in disease treatment, including cancer therapy and genetic disorders.
Applications:
RNA ingredients have a wide range of applications in various industries:
Pharmaceuticals and Biotechnology: RNA ingredients are extensively used in drug discovery, therapeutic development (including mRNA-based vaccines and gene therapy), and personalized medicine. RNA-based technologies offer new possibilities for treating diseases at the genetic level.
Agriculture and Crop Science: RNA ingredients are explored for their potential in genetic engineering and crop improvement. They can be used to modify gene expression in plants, enhancing traits such as disease resistance, yield, and nutritional content.
Research and Diagnostics: RNA ingredients are valuable tools in research laboratories for gene expression analysis, studying cellular processes, and understanding disease mechanisms. They are also used in molecular diagnostics to detect specific RNA sequences associated with diseases.
麻豆原创 Dynamics:
The global RNA ingredients market is influenced by several factors, including:
Advancements in RNA-based technologies and their increasing adoption across industries.
Growing demand for personalized medicine and targeted therapies.
Government initiatives and funding for RNA research and development.
Increased focus on genetic engineering and genetically modified organisms in agriculture.
麻豆原创 Outlook:
The global RNA ingredients market is expected to witness continued growth in the coming years, driven by ongoing advancements in RNA-based technologies, increasing research activities, and rising demand for personalized medicine. The market is likely to see new product launches, collaborations, and strategic partnerships as companies strive to innovate and cater to the evolving needs of different industries.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ribonucleic Acid Ingredients market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
BioNTech SE
Moderna
Abogen Biosciences
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
LARONDE, Inc.
Sirnaomics, Inc.
Deep Genomics
Nutcracker Therapeutics
Segment by Type
Messenger RNA
Transfer RNA
Ribosomal RNA
Segment by Application
Fluorescent Dyes
RT-PCR Enzymes
Transcription Reagents
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Ribonucleic Acid Ingredients report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Ribonucleic Acid Ingredients 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Messenger RNA
1.2.3 Transfer RNA
1.2.4 Ribosomal RNA
1.3 麻豆原创 by Application
1.3.1 Global Ribonucleic Acid Ingredients 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Fluorescent Dyes
1.3.3 RT-PCR Enzymes
1.3.4 Transcription Reagents
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ribonucleic Acid Ingredients 麻豆原创 Perspective (2018-2029)
2.2 Ribonucleic Acid Ingredients Growth Trends by Region
2.2.1 Global Ribonucleic Acid Ingredients 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Ribonucleic Acid Ingredients Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Ribonucleic Acid Ingredients Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Ribonucleic Acid Ingredients 麻豆原创 Dynamics
2.3.1 Ribonucleic Acid Ingredients Industry Trends
2.3.2 Ribonucleic Acid Ingredients 麻豆原创 Drivers
2.3.3 Ribonucleic Acid Ingredients 麻豆原创 Challenges
2.3.4 Ribonucleic Acid Ingredients 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ribonucleic Acid Ingredients Players by Revenue
3.1.1 Global Top Ribonucleic Acid Ingredients Players by Revenue (2018-2023)
3.1.2 Global Ribonucleic Acid Ingredients Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Ribonucleic Acid Ingredients 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ribonucleic Acid Ingredients Revenue
3.4 Global Ribonucleic Acid Ingredients 麻豆原创 Concentration Ratio
3.4.1 Global Ribonucleic Acid Ingredients 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ribonucleic Acid Ingredients Revenue in 2022
3.5 Ribonucleic Acid Ingredients Key Players Head office and Area Served
3.6 Key Players Ribonucleic Acid Ingredients Product Solution and Service
3.7 Date of Enter into Ribonucleic Acid Ingredients 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Ribonucleic Acid Ingredients Breakdown Data by Type
4.1 Global Ribonucleic Acid Ingredients Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Ribonucleic Acid Ingredients Forecasted 麻豆原创 Size by Type (2024-2029)
5 Ribonucleic Acid Ingredients Breakdown Data by Application
5.1 Global Ribonucleic Acid Ingredients Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Ribonucleic Acid Ingredients Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Ribonucleic Acid Ingredients 麻豆原创 Size (2018-2029)
6.2 North America Ribonucleic Acid Ingredients 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2018-2023)
6.4 North America Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ribonucleic Acid Ingredients 麻豆原创 Size (2018-2029)
7.2 Europe Ribonucleic Acid Ingredients 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2018-2023)
7.4 Europe Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ribonucleic Acid Ingredients 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Ribonucleic Acid Ingredients 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Ribonucleic Acid Ingredients 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Ribonucleic Acid Ingredients 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ribonucleic Acid Ingredients 麻豆原创 Size (2018-2029)
9.2 Latin America Ribonucleic Acid Ingredients 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ribonucleic Acid Ingredients 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Ribonucleic Acid Ingredients 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Ribonucleic Acid Ingredients 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioNTech SE
11.1.1 BioNTech SE Company Detail
11.1.2 BioNTech SE Business Overview
11.1.3 BioNTech SE Ribonucleic Acid Ingredients Introduction
11.1.4 BioNTech SE Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.1.5 BioNTech SE Recent Development
11.2 Moderna
11.2.1 Moderna Company Detail
11.2.2 Moderna Business Overview
11.2.3 Moderna Ribonucleic Acid Ingredients Introduction
11.2.4 Moderna Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.2.5 Moderna Recent Development
11.3 Abogen Biosciences
11.3.1 Abogen Biosciences Company Detail
11.3.2 Abogen Biosciences Business Overview
11.3.3 Abogen Biosciences Ribonucleic Acid Ingredients Introduction
11.3.4 Abogen Biosciences Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.3.5 Abogen Biosciences Recent Development
11.4 Ionis Pharmaceuticals
11.4.1 Ionis Pharmaceuticals Company Detail
11.4.2 Ionis Pharmaceuticals Business Overview
11.4.3 Ionis Pharmaceuticals Ribonucleic Acid Ingredients Introduction
11.4.4 Ionis Pharmaceuticals Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.4.5 Ionis Pharmaceuticals Recent Development
11.5 Sarepta Therapeutics
11.5.1 Sarepta Therapeutics Company Detail
11.5.2 Sarepta Therapeutics Business Overview
11.5.3 Sarepta Therapeutics Ribonucleic Acid Ingredients Introduction
11.5.4 Sarepta Therapeutics Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.5.5 Sarepta Therapeutics Recent Development
11.6 Alnylam Pharmaceuticals
11.6.1 Alnylam Pharmaceuticals Company Detail
11.6.2 Alnylam Pharmaceuticals Business Overview
11.6.3 Alnylam Pharmaceuticals Ribonucleic Acid Ingredients Introduction
11.6.4 Alnylam Pharmaceuticals Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.6.5 Alnylam Pharmaceuticals Recent Development
11.7 LARONDE, Inc.
11.7.1 LARONDE, Inc. Company Detail
11.7.2 LARONDE, Inc. Business Overview
11.7.3 LARONDE, Inc. Ribonucleic Acid Ingredients Introduction
11.7.4 LARONDE, Inc. Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.7.5 LARONDE, Inc. Recent Development
11.8 Sirnaomics, Inc.
11.8.1 Sirnaomics, Inc. Company Detail
11.8.2 Sirnaomics, Inc. Business Overview
11.8.3 Sirnaomics, Inc. Ribonucleic Acid Ingredients Introduction
11.8.4 Sirnaomics, Inc. Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.8.5 Sirnaomics, Inc. Recent Development
11.9 Deep Genomics
11.9.1 Deep Genomics Company Detail
11.9.2 Deep Genomics Business Overview
11.9.3 Deep Genomics Ribonucleic Acid Ingredients Introduction
11.9.4 Deep Genomics Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.9.5 Deep Genomics Recent Development
11.10 Nutcracker Therapeutics
11.10.1 Nutcracker Therapeutics Company Detail
11.10.2 Nutcracker Therapeutics Business Overview
11.10.3 Nutcracker Therapeutics Ribonucleic Acid Ingredients Introduction
11.10.4 Nutcracker Therapeutics Revenue in Ribonucleic Acid Ingredients Business (2018-2023)
11.10.5 Nutcracker Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

BioNTech SE
Moderna
Abogen Biosciences
Ionis Pharmaceuticals
Sarepta Therapeutics
Alnylam Pharmaceuticals
LARONDE, Inc.
Sirnaomics, Inc.
Deep Genomics
Nutcracker Therapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.